Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,051 | 37,329 | 68,467 | 99,664 | 80,981 |
| Marketable Securities | 72,814 | 16,135 | 12,006 | 79,721 | 101,623 |
| Receivables | 4,470 | N/A | 39 | 27 | 7,191 |
| Other current assets | 1,716 | 1,923 | 911 | 3,536 | 3,863 |
| TOTAL | $133,051 | $55,387 | $81,423 | $182,948 | $193,658 |
| Non-Current Assets | |||||
| PPE Net | 1,532 | 2,695 | 6,191 | 82,598 | 91,378 |
| Investments And Advances | 3,739 | 6,411 | 21,057 | 0 | 0 |
| Other Non-Current Assets | 6,102 | 6,325 | 9,511 | 11,108 | 104,641 |
| TOTAL | $11,373 | $15,431 | $36,759 | $93,706 | $196,019 |
| Total Assets | $144,424 | $70,818 | $118,182 | $276,654 | $389,677 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 1,486 | 4,489 |
| Accounts payable and accrued liabilities | 810 | 2,188 | 1,599 | 3,776 | 3,213 |
| Accrued Expenses | 8,603 | 6,240 | 10,905 | 21,717 | 12,414 |
| Other current liabilities | N/A | 1,436 | N/A | N/A | N/A |
| TOTAL | $52,777 | $19,961 | $26,094 | $29,907 | $20,116 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 49,152 |
| Deferred Revenues | 39,979 | 5,808 | 5,720 | 2,928 | N/A |
| Other Non-Current Liabilities | 1,514 | 906 | 3,244 | 4,710 | 5,693 |
| TOTAL | $72,302 | $46,903 | $55,314 | $128,050 | $54,845 |
| Total Liabilities | $125,079 | $66,864 | $81,408 | $157,957 | $74,961 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,887 | 44,062 | 38,674 | 38,274 | 37,906 |
| Common Shares | 55 | 44 | 39 | 38 | 38 |
| Retained earnings | -762,269 | -754,301 | -703,263 | -614,650 | -407,351 |
| Other shareholders' equity | -48 | 1,209 | -1,570 | -233 | 99 |
| TOTAL | $19,345 | $3,954 | $36,774 | $118,697 | $314,716 |
| Total Liabilities And Equity | $144,424 | $70,818 | $118,182 | $276,654 | $389,677 |